Table 3.
The AUC for Detecting Any VIP-Targeted Condition and Group 1 Conditions
| Screener | AUC (95% CI) |
||
|---|---|---|---|
| Any VIP-Targeted Condition | Group 1 Conditions | ||
| VIP Phase I, Year 1 (n = 1142) | (n = 346) | (n = 139) | |
| NCR | LEP | 0.84 (0.81–0.87) | 0.95 (0.92–0.97) |
| Retinomax | LEP | 0.83 (0.80–0.86) | 0.95 (0.94–0.97) |
| P for AUC comparison between instruments | 0.75 | 0.51 | |
| VIP Phase I, Year 2 (n = 1446) | (n = 409) | (n = 172) | |
| Retinomax | LEP | 0.86 (0.84–0.88) | 0.93 (0.91–0.96) |
| SureSight | LEP | 0.86 (0.84–0.88) | 0.94 (0.92–0.96) |
| P for AUC comparison between instruments | 0.93 | 0.59 | |
| VIP Phase II (n = 1452) | (n = 462) | (n = 210) | |
| Retinomax | Nurse | 0.88 (0.86–0.90) | 0.95 (0.93–0.97) |
| Lay | 0.88 (0.86–0.90) | 0.95 (0.93–0.97) | |
| P for AUC comparison between screeners | 0.90 | 0.86 | |
| SureSight | Nurse | 0.87 (0.85–0.90) | 0.95 (0.94–0.97) |
| Lay | 0.87 (0.85–0.89) | 0.95 (0.93–0.97) | |
| P for AUC comparison between screeners | 0.60 | 0.88 | |
| P for AUC comparison between instruments | 0.88 | 0.94 | |
LEP, licensed eye care professionals; Nurse, trained and certified pediatric nurse screeners; Lay, study trained lay screeners.